G. Steffensen et Na. Aunsholt, DOES ERYTHROPOIETIN CAUSE HORMONAL CHANGES IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 8(11), 1993, pp. 1215-1218
In 10 female and 10 male haemodialysis patients plasma FSH, LH, testos
terone, prolactin, and somatotropin (STH) were estimated during erythr
opoietin (rHuEpo) treatment for 6 months. All but one patient responde
d with an increase in haemoglobin. The patients experienced improved s
exual function according to the answers given in a self-administered q
uestionnaire. Of the 90% who answered before the study 22% could not p
erform sexual activities whether they wanted to or not. During and at
the end of the study 80 and 60% respectively answered, and none had th
ese problems. In contrast, serum values of the sexual hormones (FSH, L
H, testosterone and prolactin) were not significantly changed during r
HuEpo therapy, and neither was the basal plasma STH.